Glycosaminoglycans in Neurodegenerative Diseases
- PMID: 34495536
- DOI: 10.1007/978-3-030-70115-4_9
Glycosaminoglycans in Neurodegenerative Diseases
Abstract
Glycosaminoglycans (GAGs) are linear polysaccharides that consist of alternating disaccharides sequences of uronic acids and/or galactose hexamino sugars most of which are sulfated. GAGs are ubiquitously expressed on the cell surface, in the intracellular milieu and in the extracellular matrix of all animal cells. Thus, GAGs exhibit many essential roles in a variety of physiological and pathological processes. The targets of GAGs are GAG-binding proteins and related proteins that are of significant interest to both the academic community and in the pharmaceutical industry. In this review, the structures of GAGs, their binding proteins, and analogs are presented that further the development of GAGs and their analogs for the treatment of neurodegenerative diseases agents.
Keywords: Alzheimer’s disease; Glycosaminoglycans; Heparan sulfate; Neurodegenerative diseases; Parkinson’s disease.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Glycosaminoglycan Analysis: Purification, Structural Profiling, and GAG-Protein Interactions.Methods Mol Biol. 2023;2597:159-176. doi: 10.1007/978-1-0716-2835-5_13. Methods Mol Biol. 2023. PMID: 36374421
-
Targeting heparin and heparan sulfate protein interactions.Org Biomol Chem. 2017 Jul 21;15(27):5656-5668. doi: 10.1039/c7ob01058c. Epub 2017 Jun 27. Org Biomol Chem. 2017. PMID: 28653068 Free PMC article. Review.
-
Sulfated glycosaminoglycans in protein aggregation diseases.Glycoconj J. 2017 Aug;34(4):453-466. doi: 10.1007/s10719-017-9769-4. Epub 2017 Apr 11. Glycoconj J. 2017. PMID: 28401373 Review.
-
Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.J Surg Res. 2000 Jul;92(1):45-52. doi: 10.1006/jsre.2000.5840. J Surg Res. 2000. PMID: 10864481
-
New Applications of Heparin and Other Glycosaminoglycans.Molecules. 2017 May 6;22(5):749. doi: 10.3390/molecules22050749. Molecules. 2017. PMID: 28481236 Free PMC article. Review.
Cited by
-
In-Depth Molecular Dynamics Study of All Possible Chondroitin Sulfate Disaccharides Reveals Key Insight into Structural Heterogeneity and Dynamism.Biomolecules. 2022 Jan 5;12(1):77. doi: 10.3390/biom12010077. Biomolecules. 2022. PMID: 35053225 Free PMC article.
-
Serum Amyloid A Binding to Glycosaminoglycans is Synergistic with Amyloid Formation: Therapeutic Targeting in the Inflammation-linked Amyloidosis.J Mol Biol. 2025 Apr 15;437(8):169007. doi: 10.1016/j.jmb.2025.169007. Epub 2025 Feb 13. J Mol Biol. 2025. PMID: 39954777
-
Molecular Dynamics Approaches Dissect Molecular Mechanisms Underlying Methylene Blue-Glycosaminoglycan Interactions.Molecules. 2022 Apr 20;27(9):2654. doi: 10.3390/molecules27092654. Molecules. 2022. PMID: 35566005 Free PMC article.
-
High-throughput glycosaminoglycan extraction and UHPLC-MS/MS quantification in human biofluids.Nat Protoc. 2025 Apr;20(4):843-860. doi: 10.1038/s41596-024-01078-9. Epub 2024 Nov 14. Nat Protoc. 2025. PMID: 39543382 Review.
-
Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease.Int J Mol Sci. 2022 Jun 8;23(12):6400. doi: 10.3390/ijms23126400. Int J Mol Sci. 2022. PMID: 35742845 Free PMC article. Review.
References
-
- Alberts B, Johnson A, Lewis J, Morgan D, Raff M, Roberts K et al (2015) Cell junctions and the extracellular matrix. In: Molecular biology of the cell. Garland Science, New York
-
- Alzheimer’s Association (2020) Alzheimer’s disease facts and figures (2020). Alzheimers Dement
-
- Appel SH, Smith RG, Le WD (1996) Immune-mediated cell death in neurodegenerative disease. Adv Neurol 69:153–159 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical